📰Thrilled to see Dr Jordan and Dr Karumanchi's new study in @NatureComms! "Butyrophilin 2A2 promotes T cell immunoregulation via CD45 phosphatase activation and protects against murine autoimmune glomerulonephritis and pregnancy loss" is available now. ➡️doi.org/10.1038/s41467-025-6…
We are extremely excited to see our "Five Years Follow-up of Imlifidase Desensitized Kidney Transplant Recipients" published in @Transpl_Int! Available at: doi.org/10.3389/ti.2025.1542…
We are delighted to see our publication "Tocilizumab (Actemra) Treatment for Microvascular Inflammation and Chronic Active Antibody-mediated Rejection in Kidney #Transplantation" in @TXPDirect! Available at: pmc.ncbi.nlm.nih.gov/article…
We were excited to see our Case Report "An Unusual Presentation of Bullous Skin Lesions During Pregnancy" published in the Journal of Investigative Medicine High Impact Case Reports. Available at: journals.sagepub.com/doi/10.…#casereport
Dr Jordan's "Anti-CD38 Monoclonals for Treatment of
Antibody-mediated Rejection in Renal Allografts" is now available in @TransplantJrnl! Go to pubmed.ncbi.nlm.nih.gov/3927… for more!
We are excited to see Dr Sanjeev Kumar presenting the @ASNKidney AKINow Journal Club! June 20th, at 12 pm EDT, featuring his @ScienceMagazine article "SOX9 Switch Links Regeneration to Fibrosis at the Single-Cell Level in Mammalian #Kidneys" Register at: asn-online.org/AKINowJournal…
33
Transplant Immunotherapy Program Los Angeles retweeted
Now at #ATC2024Philly : A prospective observational study including 2,882 kidney allograft recipients from 14 centers in Europe and the US shows that cell-free DNA can be used to detect kidney allograft rejection @AlexandreLoupy @olivieraubert nature.com/articles/s41591-0…
Dr Ashley Vo and Dr Stan Jordan will both present at the
@ATCMeeting Oral Abstract Session #Kidney Immunosuppression: #Desensitization on 6/5! Presenting at 9:30 on Daratumumab and 9:40 am on Imlifidase 5 year analysis! Hope to see you there! #ATC2024Philly
📍108-AB, Level 1
Our final oral abstract @ATCMeeting will be presented by Dr Stan Jordan on 6/5 at 10:20 am during the Oral Abstract Session: Kidney IS Novel Regimens! ➡️Please join him for "CTLA-4Ig + Anti-IL6/IL6R in Long-Term Rejection-Free Graft Survival" 📊#ATC2024Philly
📍107-AB, Level 1
Dr Ashley Vo will be at the @ATCMeeting Poster Session: #Kidney IS Desensitization starting soon! 6/4 at 9:15- 10 am. Please stop by to discuss her posters on 5 Year #Clazakizumab Data and Impact of AT1R antibody on allograft outcomes! #ATC2024Philly
📍Exhibit Hall A, Level 2
Dr Edmund Huang will be presenting his IIT results at the @ATCMeeting, Tues 6/4 at 1:30 pm "Comparison of Tacrolimus Extended-Release (#Envarsus XR) to Tacrolimus Immediate- Release in HLA Sensitized
#Kidney Transplant Recipients (NCT04225988) #ATC2024Philly
📍115-ABC, Level 1
Tomorrow, 📆6/3 at @ATCMeeting, join Dr Edmund Huang presenting an oral abstract at 3 pm ➡️ "Tissue Gene Expression Suggests Alternative Mechanisms of Injury in Chronic Active T-cell Mediated Rejection"! 📈We hope to see you there!
📍108-AB, Level 1 #ATC2024Philly
Lastly today at the @ATCMeeting 📆6/2 at 4:50 pm, join David Thomas presenting "Nanostring Assessment of #Kidney Transplant Biopsies Using the Banff Human Organ Transplant (BHOT) Panel Effectively Distinguishes between AMR and Non-AMR Conditions"
📍107-AB, Level 1 #ATC2024Philly
Join Dr Steven Wisel for his oral abstract today at the @ATCMeeting! 📆6/2 at 3:40 pm, "Nationwide Use of Machine Perfusion Demonstrates Increased Organ Utilization and Improved DCD Graft Survival in #Liver#Transplantation"
📍204-ABC, Level 2 #ATC2024Philly
Join our team for several oral abstract sessions today at the @ATCMeeting! Our first is Dr Peter Heeger, 📆6/2 at 3:20 pm, "Utility of Donor-Derived Cell-Free DNA Monitoring for Rejection in the CTOT19 Cohort" 📊
Nutter Theater, Level 1 (114) #ATC2024Philly
We are excited to see Dr Kumar's work on dynamic SOX9 published in @ScienceMagazine! "SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian #kidneys" is now available at: tinyurl.com/yc3cczn5
Dr Zhang and Dr Jordan's "Assessment of IgM DSAs in Transplant Recipients: Relationship to De Novo IgG #DSAs and Risk for Antibody Rejection" is available in @TXPDirect! ➡️Access their evaluation of IgM DSAs an an early indicator before dnDSAs at: pubmed.ncbi.nlm.nih.gov/3838…
Dr Jordan's article, "Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS-CoV-2 infections in solid organ #transplant recipients" is online now! Honored to be featured on the cover of @TheTxIDjournal! Access it here📰↘️ onlinelibrary.wiley.com/doi/…